UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer

被引：0
|
作者：
Yoshinori Miyata
Tetsuo Touyama
Takaya Kusumi
Yoshitaka Morita
Nobuyuki Mizunuma
Fumihiro Taniguchi
Mitsuaki Manabe
机构：
[1] Saku Central Hospital Advanced Care Center,Department of Medical Oncology
[2] Nakagami Hospital,Department of Surgery
[3] Keiyukai Sapporo Hospital,Department of Surgery
[4] National Hospital Organization Kobe Medical Center,Department of Radiology
[5] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[6] Japanese Red Cross Kyoto Daiichi Hospital,Hepato
[7] Yakult Honsha Co.,Pancreatic Surgery Division
[8] Ltd.,undefined
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Colorectal; Irinotecan; Neutropenia; Polymorphism; UGT1A1 enzyme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：696 / 703
页数：7
相关论文
共 50 条
  • [31] Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial
    Cheng-Jen Ma
    Tsung-Kun Chang
    Hsiang-Lin Tsai
    Wei-Chih Su
    Ching-Wen Huang
    Yung-Sung Yeh
    Yu-Tang Chang
    Jaw-Yuan Wang
    Trials, 20
  • [32] Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial
    Ma, Cheng-Jen
    Chang, Tsung-Kun
    Tsai, Hsiang-Lin
    Su, Wei-Chih
    Huang, Ching-Wen
    Yeh, Yung-Sung
    Chang, Yu-Tang
    Wang, Jaw-Yuan
    TRIALS, 2019, 20 (01)
  • [33] Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting
    Lu, Chien-Yu
    Huang, Ching-Wen
    Hu, Huang-Ming
    Tsai, Hsiang-Lin
    Huang, Chun-Ming
    Yu, Fang-Jung
    Huang, Ming-Yii
    Chang, Se-Fen
    Huang, Meng-Lin
    Wang, Jaw-Yuan
    TRANSLATIONAL RESEARCH, 2014, 164 (02) : 169 - 176
  • [34] The prognostic impact of UDP-glucuronyltransferase 1A1*1 (UGT1A1*1) polymorphism in patients with advanced colorectal and non-colorectal cancer treated with irinotecan-based systemic chemotherapies
    Stein, G.
    Stelmach, P.
    Kasper, S.
    Paul, A.
    Wedemeyer, H. H.
    Schmid, K. W.
    Schumacher, B.
    Markus, P.
    Siffert, W.
    Schuler, M.
    Bachmann, H. S.
    Virchow, I
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 122 - 123
  • [35] UGT1A1*28 genotype and irinotecan dose adaptation in patients with metastatic colorectal cancer (MCRC) - A dutch colorectal cancer group (DCCG) study
    Kweekel, Dina M.
    Gelderblom, Hans
    van der Straaten, Tahar
    Punt, Cornelis J.
    Guchelaar, Henk-Jan
    ANNALS OF ONCOLOGY, 2006, 17 : 257 - 257
  • [36] UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer
    Yu Sunakawa
    Wataru Ichikawa
    Ken-ichi Fujita
    Fumio Nagashima
    Hiroo Ishida
    Keishi Yamashita
    Keiko Mizuno
    Keisuke Miwa
    Kaori Kawara
    Yuko Akiyama
    Kazuhiro Araki
    Wataru Yamamoto
    Toshimichi Miya
    Masaru Narabayashi
    Yuichi Ando
    Takashi Hirose
    Shigehira Saji
    Yasutsuna Sasaki
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 279 - 284
  • [37] UGT1A1*1/*28 and*1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer
    Sunakawa, Yu
    Ichikawa, Wataru
    Fujita, Ken-ichi
    Nagashima, Fumio
    Ishida, Hiroo
    Yamashita, Keishi
    Mizuno, Keiko
    Miwa, Keisuke
    Kawara, Kaori
    Akiyama, Yuko
    Araki, Kazuhiro
    Yamamoto, Wataru
    Miya, Toshimichi
    Narabayashi, Masaru
    Ando, Yuichi
    Hirose, Takashi
    Saji, Shigehira
    Sasaki, Yasutsuna
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 279 - 284
  • [38] Prospective investigation of association between UGT1A1 polymorphisms and irinotecan toxicity in Korean patients with advanced colorectal or gastric cancer treated with FOLFIRI regimen
    Kim, K. P.
    Kim, T. W.
    Hong, Y. S.
    Kim, S. Y.
    Park, S. R.
    Nam, B. H.
    Lee, K. W.
    Kim, J. H.
    Chung, I. J.
    Park, Y. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S513 - S514
  • [39] Polymorphisms in sulfotransferase 1A1 and glutathione 5-transferase P1 genes in relation to colorectal cancer risk and patients' survival
    Ahmad Ahmadi
    Gunnar Arbman
    sa Wallin
    Daniel Asklid
    World Journal of Gastroenterology, 2005, (43) : 6875 - 6879
  • [40] Polymorphisms in sulfotransferase 1A1 and glutathione S-transferase P1 genes in relation to colorectal cancer risk and patients' survival
    Sun, Xiao-Feng
    Ahmadi, Ahmad
    Arbman, Gunnar
    Wallin, Asa
    Asklid, Daniel
    Zhang, Hong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (43) : 6875 - 6879
12345